AIRE Medical of Los Angeles

Santa Monica, California 90404

0 studies enrolling now · 9 studies all time

What they study most

Angioedema, Hereditary Angioedema, Hereditary Angioedema (HAE), Primary Immunodeficiency

Studies at this site

• A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) — Completed
• Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults — NO_LONGER_AVAILABLE
• A Study to Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema — Completed
• A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America — Completed
• A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children — Completed
• Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema — Completed
• Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE — Completed
• Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency — Completed